Herbst Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.2M Buy
4,339
+346
+9% +$354K 2.84% 7
2026
Q1
$3.67M Buy
3,993
+2,068
+107% +$2.1M 2.27% 17
2025
Q4
$2.07M Buy
+1,925
New +$1.84M 1.22% 36
2025
Q1
Sell
-3,451
Closed -$2.66M 66
2024
Q4
$2.66M Sell
3,451
-4,163
-55% -$3.45M 1.66% 29
2024
Q3
$6.75M Sell
7,614
-800
-10% -$719K 4.18% 2
2024
Q2
$7.62M Sell
8,414
-28
-0.3% -$22.4K 4.63% 2
2024
Q1
$6.57M Sell
8,442
-1,020
-11% -$726K 4.06% 2
2023
Q4
$5.52M Sell
9,462
-828
-8% -$483K 3.54% 4
2023
Q3
$5.53M Sell
10,290
-973
-9% -$501K 3.95% 2
2023
Q2
$5.28M Sell
11,263
-387
-3% -$162K 3.65% 3
2023
Q1
$4M Buy
11,650
+4,525
+64% +$1.53M 2.83% 8
2022
Q4
$2.61M Buy
7,125
+4,825
+210% +$1.71M 2.11% 17
2022
Q3
$744K Buy
+2,300
New +$729K 0.61% 58

Other funds holding LLY

Herbst Group's LLY Position: Q2 2026 in Review

Herbst Group increased its Eli Lilly (LLY) stake by 8.7% in Q2 2026, buying an estimated $354K and bringing the position to 4,339 shares worth $5.2M. The position accounts for 2.84% of the portfolio, ranked #7.

Herbst Group first reported a position in LLY in Q3 2022 and has held it in 13 quarters since. The position peaked at $7.62M in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Herbst Group held 4,339 shares of Eli Lilly worth $5.2M as of Q2 2026.
  • Herbst Group bought 346 Eli Lilly shares in Q2 2026, an estimated $354K.
  • Eli Lilly made up 2.84% of Herbst Group's portfolio in Q2 2026, its #7 holding.
  • Herbst Group first reported a position in Eli Lilly in Q3 2022 and has held it in 13 quarters since.
  • Herbst Group's Eli Lilly position peaked at $7.62M in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Herbst Group's 13F filing for Q2 2026, filed 9 Jul 2026.